Douglas Weckstein MD in Concord, New Hampshire

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: Virginia Commonwealth University, School Of Medicine
Graduation Year: 1986
The Primary Medical Specialty for Douglas Weckstein MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 4284604893
NPI #: 1710971684
NPI Created On: 09/07/2005
NPI Last Updated Listed as: 02/15/2008
Primary Taxonomy Code: 207RX0202X
License Number:
10352
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
4. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
5. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
6. Infusion of chemotherapy into a vein up to 1 hour
7. Infusion of chemotherapy into a vein
8. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
9. Established patient office or other outpatient visit, typically 5 minutes
10. Established patient office or other outpatient visit, typically 10 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Injection, dexamethasone sodium phosphate, 1 mg
17. Injection, palonosetron hcl, 25 mcg
18. Leuprolide acetate (for depot suspension), 7.5 mg